Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Charles Hannum is active.

Publication


Featured researches published by Charles Hannum.


Cell | 1983

The major histocompatibility complex-restricted antigen receptor on T cells in mouse and man: Identification of constant and variable peptides

John W. Kappler; Ralph T. Kubo; Kathryn Haskins; Charles Hannum; Philippa Marrack; Michele Pigeon; Bradley W. McIntyre; James P. Allison; Ian S. Trowbridge

The variability of the MHC restricted receptor on murine T cells was examined by comparing tryptic peptide fingerprints of the receptor isolated fom three T cell hybridomas and a T cell tumor. Both variable and constant peptides were seen. Constant peptides were most apparent when comparing receptors from the same mouse strain. Peptide fingerprints of receptors from two independent T cell hybridomas with the same idiotype and specificity were identical. We also describe a molecule detected on the surface of a human T cell leukemia whose properties were identical to those reported for the MHC receptor on normal human T cells. The molecule was a dimer of 85,000-90,000 MW containing a 46,000 MW acidic alpha-chain and an unrelated 40,000 MW neutral beta-chain.


Archive | 1985

The Murine T Cell Receptor

Kathryn Haskins; Neal Roehm; Charles Hannum; Janice White; Ralph T. Kubo; Philippa Marrack; John Kappler

In the past two years, the major histocompatibility complex (MHC)-restricted receptor for antigen on T cells has been identified by several laboratories through the use of clone-specific antibodies which recognize idiotypic determinants on T cell antigen receptors. Studies with these antibodies, summarized in a recent review (1) have established that the antigen/MHC recognition structures on T cells (a) are idiotypic molecules as indicated by the highly specific nature of their binding to the anti-receptor antibodies; (b) can be functionally inhibited or stimulated through interaction with clone-specific antibodies, suggesting that the specific recognition of antigen and MHC involves a single binding site; (c) are 85–90,000 dalton glycoproteins consisting of two heterodimeric disulfide-linked subunits; and (d) contain variable and constant peptide regions in both the alpha and the beta chains. The biochemical characterization of the receptor with the clone-specific antibodies has since been confirmed and extended by recent reports on the genomic organization of the receptor β chain (2–6).


Nature | 1990

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist.

Stephen P. Eisenberg; Ronald Evans; William P. Arend; Evie Verderber; Michael T Brewer; Charles Hannum; Robert C. Thompson


Nature | 1990

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor.

Charles Hannum; Carol J. Wilcox; William P. Arend; Fenneke G. Joslin; David Dripps; Patricia L. Heimdal; Lyman G. Armes; Andreas Sommer; Stephen P. Eisenberg; Robert C. Thompson


Journal of Immunology | 1989

An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties.

William P. Arend; Fenneke G. Joslin; R C Thompson; Charles Hannum


Journal of Experimental Medicine | 1983

The major histocompatibility complex-restricted antigen receptor on T cells. IV. An antiidiotypic antibody predicts both antigen and I-specificity.

Philippa Marrack; Richard Shimonkevitz; Charles Hannum; Kathryn Haskins; John W. Kappler


Nature | 1984

Immunoglobulin-like nature of the α-chain of a human T-cell antigen/MHC receptor

Charles Hannum; John W. Kappler; Ian S. Trowbridge; Philippa Marrack; John H. Freed


Journal of Experimental Medicine | 1987

Thymocytes with the predicted properties of pre-T cells

Charles Hannum; Philippa Marrack; Ralph T. Kubo; John W. Kappler


Journal of Immunology | 2006

The major histocompatibility complex-restricted antigen receptor on T cells in mouse and man: identification of constant and variable peptides. 1983.

John W. Kappler; Ralph T. Kubo; Kathryn Haskins; Charles Hannum; Philippa Marrack; Michele Pigeon; Bradley W. McIntyre; James P. Allison; Ian S. Trowbridge


Archive | 2000

INTERLEUKIN-1 INHIBITOR

William P. Arend; Stephen P. Eisenburg; Charles Hannum; Fenneke G. Joslin; Andreas Sommer; Robert C. Thompson; アレンド,ウィリアム,ピー.; エイゼンバーグ,ステファン,ピー.; ジョスリン,フェネック,ジー.; ソマー,アンドリアス; トムプソン,ロバート,シー.; ハノン,チャールズ,エッチ.

Collaboration


Dive into the Charles Hannum's collaboration.

Top Co-Authors

Avatar

William P. Arend

University of Colorado Denver

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert C. Thompson

University of Colorado Boulder

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Philippa Marrack

University of Colorado Denver

View shared research outputs
Top Co-Authors

Avatar

Stephen P. Eisenberg

University of Colorado Boulder

View shared research outputs
Top Co-Authors

Avatar

John W. Kappler

University of Colorado Denver

View shared research outputs
Top Co-Authors

Avatar

Kathryn Haskins

University of Colorado Denver

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ian S. Trowbridge

Salk Institute for Biological Studies

View shared research outputs
Researchain Logo
Decentralizing Knowledge